How does tirzepatide ordering work on Olympia Pharmacy?

Tirzepatide programs run across a wide titration range — clinical dose escalation spans from 2.5 mg to 15 mg per dose, and compounded vials are sized accordingly. The landed cost per vial can change as the patient escalates, making the ordering question economic rather than purely operational: to price a protocol you need per-vial 503A cost at each step, not a single blended rate. Olympia Pharmacy compounds tirzepatide through its own 503A and 503B programs; exact concentrations and rates are not published publicly and flow through clinic agreements.

This page covers ordering workflow and economics, not clinical dosing. The titration schedule is a prescriber decision; the platform's job is to make the right vial reach the patient with a correct SIG and show what each step costs. What you should evaluate is whether the platform surfaces per-vial cost and pre-submit validation so the protocol orders cleanly and predictably.

The dominant pitfall is opaque per-step pricing. Olympia Pharmacy pricing flows through clinic agreements rather than a per-SKU catalog, so a program owner cannot model margin at each tirzepatide step until a sales or liaison conversation. When a protocol spans a wide dose range, one blended agreement rate can hide where the program loses money at the higher steps. The second pitfall is validation timing: a wrong vial for the step, a SIG error, or a licensure mismatch should surface before payment, not after Olympia rejects the order.

Fizy Health is a multi-pharmacy 503A ordering platform — not a compounder — and is built around these pressure points. Per-vial 503A cost shows on each catalog and cart line before checkout, so you can price each protocol step on a real number; the whole refill day goes into one validated clinic cart; and steady patients can move to auto-ship so the program keeps shipping on schedule. If you need Olympia specifically, Olympia ordering stays in DrScript; Fizy Health covers the multi-compounder batch layer.